Associations of CYP2A6 genotype with smoking behaviors in southern China

被引:43
|
作者
Liu, Tao [1 ]
David, Sean P. [2 ,3 ,4 ,5 ,6 ]
Tyndale, Rachel F. [7 ,8 ,9 ]
Wang, Hui [1 ]
Zhou, Qian [7 ,8 ,9 ]
Ding, Peng [1 ]
He, Yan-Hui [1 ]
Yu, Xue-Qing [10 ]
Chen, Wei [10 ]
Crump, Casey [2 ,3 ]
Wen, Xiao-Zhong [11 ]
Chen, Wei-Qing [1 ]
机构
[1] Sun Yat Sen Univ, Sch Publ Hlth, Dept Biostat & Epidemiol, Guangzhou 510080, Guangdong, Peoples R China
[2] Stanford Univ, Ctr Educ Family & Community Med, Stanford, CA 94305 USA
[3] Stanford Univ, Div Family & Community Med, Stanford, CA 94305 USA
[4] SRI Int, Menlo Pk, CA 94025 USA
[5] Brown Alpert Med Sch, Ctr Primary Care & Prevent, Pawtucket, RI USA
[6] Brown Alpert Med Sch, Dept Family Med, Pawtucket, RI USA
[7] Univ Toronto, Ctr Addict & Mental Hlth, Toronto, ON, Canada
[8] Univ Toronto, Dept Psychiat, Toronto, ON, Canada
[9] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON, Canada
[10] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Nephrol, Guangzhou 510275, Guangdong, Peoples R China
[11] Brown Univ, Dept Community Hlth, Providence, RI 02912 USA
基金
美国国家卫生研究院;
关键词
Chinese smokers; CYP2A6; genetic polymorphisms; nicotine dependence; smoking cessation; smoking duration; smoking initiation; smoking quantity; SINGLE NUCLEOTIDE POLYMORPHISM; CYTOCHROME-P450; 2A6; CYP2A6; NATIONAL PREVALENCE SURVEY; NICOTINE METABOLITE RATIO; EMERGING TOBACCO HAZARDS; IN-VIVO; TRANSDERMAL NICOTINE; (+)-CIS-3,5-DIMETHYL-2-(3-PYRIDYL)THIAZOLIDIN-4-ONE HYDROCHLORIDE; GENETIC POLYMORPHISMS; ENZYMATIC-ACTIVITY;
D O I
10.1111/j.1360-0443.2010.03353.x
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Aims To investigate the association of CYP2A6 genetic polymorphisms with smoking-related phenotypes in Chinese smokers. Design Case-only genetic association study. Setting Southern China. Participants A total of 1328 Han Chinese smokers who participated in a community-based chronic disease screening project in Guangzhou and Zhuhai from 2006 to 2007. Measurements All participants answered a structured questionnaire about socio-demographic status and smoking behaviors and informative alleles were genotyped for the cytochrome P450 2A6 (CYP2A6) gene (CYP2A6 *4, *5, *7, *9 and *10). Findings The frequencies of CYP2A6 *4, *5, *7, *9 and *10 alleles were 8.5, 1.2, 6.3, 13.5 and 2.4%, which corresponded to 48.9, 15.4, 24.2 and 11.5% of participants being classified as normal, intermediate, slow and poor metabolizers, respectively. Multivariate analyses in male smokers demonstrated that compared with normal metabolizers, poor metabolizers reported smoking fewer cigarettes per day [adjusted odds ratio (OR) = 0.49; 95% confidence interval (CI): 0.32-0.76], started smoking regularly later in life (adjusted OR = 1.55; 95% CI: 1.06-2.26) and, among former smokers, reported smoking for a shorter duration prior to quitting (adjusted OR = 0.33; 95% CI: 0.12-0.94). However, poor metabolizers were less likely to quit smoking and remain abstinent than normal metabolizers (adjusted OR = 0.54; 95% CI: 0.34-0.86). Conclusions Reduced metabolism function of cytochrome P450 2A6 in smokers appears to be associated with fewer cigarettes smoked, later initiation of smoking regularly, shorter smoking duration and lower likelihood of smoking cessation.
引用
收藏
页码:985 / 994
页数:10
相关论文
共 50 条
  • [1] CYP2A6 Genotype and Smoking Behavior in Current Smokers Screened for Lung Cancer
    Styn, Mindi A.
    Nukui, Tomoko
    Romkes, Marjorie
    Perkins, Kenneth A.
    Land, Stephanie R.
    Weissfeld, Joel L.
    SUBSTANCE USE & MISUSE, 2013, 48 (07) : 490 - 494
  • [2] CYP2A6 metabolism in the development of smoking behaviors in young adults
    Olfson, Emily
    Bloom, Joseph
    Bertelsen, Sarah
    Budde, John P.
    Breslau, Naomi
    Brooks, Andrew
    Culverhouse, Robert
    Chan, Grace
    Chen, Li-Shiun
    Chorlian, David
    Dick, Danielle M.
    Edenberg, Howard J.
    Hartz, Sarah
    Hatsukami, Dorothy
    Hesselbrock, Victor M.
    Johnson, Eric O.
    Kramer, John R.
    Kuperman, Samuel
    Meyers, Jacquelyn L.
    Nurnberger, John
    Porjesz, Bernice
    Saccone, Nancy L.
    Schuckit, Marc A.
    Stitzel, Jerry
    Tischfield, Jay A.
    Rice, John P.
    Goate, Alison
    Bierut, Laura J.
    ADDICTION BIOLOGY, 2018, 23 (01) : 437 - 447
  • [3] Association between CYP2A6 genotypes and smoking behavior in Lebanese smokers
    Farra, Chantal
    Assaf, Nada
    Karaky, Nathalie
    Diab, Sara
    Zaatari, Ghazi
    Cortas, Najwa
    Daher, Rose T.
    META GENE, 2020, 23
  • [4] DISTRIBUTION OF POLYMORPHIC VARIANTS OF CYP2A6 AND THEIR INVOLVEMENT IN NICOTINE ADDICTION
    Lopez-Flores, Luis A.
    Perez-Rubio, Gloria
    Falfan-Valencia, Ramces
    EXCLI JOURNAL, 2017, 16 : 174 - 196
  • [5] PharmVar GeneFocus: CYP2A6
    Langlois, Alec W. R.
    Chenoweth, Meghan J.
    Twesigomwe, David
    Scantamburlo, Giada
    Whirl-Carrillo, Michelle
    Sangkuhl, Katrin
    Klein, Teri E.
    Nofziger, Charity
    Tyndale, Rachel F.
    Gaedigk, Andrea
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 116 (04) : 948 - 962
  • [6] Functional Characterization of Cytochrome P450 2A6 Allelic Variants CYP2A6*15, CYP2A6*16, CYP2A6*21, and CYP2A6*22
    Tiong, Kai Hung
    Yiap, Beow Chin
    Tan, Eng Lai
    Ismail, Rusli
    Ong, Chin Eng
    DRUG METABOLISM AND DISPOSITION, 2010, 38 (05) : 745 - 751
  • [7] A novel CYP2A6 allele (CYP2A6*35) resulting in an amino-acid substitution (Asn438Tyr) is associated with lower CYP2A6 activity in vivo
    Al Koudsi, Nael
    Ahluwalia, Jasjit S.
    Lin, Shih-Ku
    Sellers, Edward M.
    Tyndale, Rachel F.
    PHARMACOGENOMICS JOURNAL, 2009, 9 (04) : 274 - 282
  • [8] Comparisons of CYP2A6 Genotype and Enzyme Activity between Swedes and Koreans
    Djordjevic, Natasa
    Antonio Carrillo, Juan
    van den Broek, Marieke P. J.
    Kishikawa, Junko
    Roh, Hyung-Keun
    Bertilsson, Leif
    Aklillu, Eleni
    DRUG METABOLISM AND PHARMACOKINETICS, 2013, 28 (02) : 93 - 97
  • [9] Association of Nicotine Metabolite Ratio and CYP2A6 Genotype With Smoking Cessation Treatment in African-American Light Smokers
    Ho, M. K.
    Mwenifumbo, J. C.
    Al Koudsi, N.
    Okuyemi, K. S.
    Ahluwalia, J. S.
    Benowitz, N. L.
    Tyndale, R. F.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 85 (06) : 635 - 643
  • [10] Variation in CYP2A6 Activity and Personalized Medicine
    Tanner, Julie-Anne
    Tyndale, Rachel F.
    JOURNAL OF PERSONALIZED MEDICINE, 2017, 7 (04):